A massive funding round in healthcare administration reveals that investors are betting on automated billing engines to solve the industry's most expensive back-office headache.
A new ensemble AI model predicts positive surgical margins before breast-conserving surgery, but its performance drop in external testing highlights the ongoing struggle with clinical generalization.
Measuring a single protein has been the gold standard for tracking ALS, but a new multi-protein signature suggests we have been missing the bigger biological picture.
A new multi-center model uses basic clinical data to flag brain metastasis before symptoms appear, challenging the need for expensive, complex biomarkers.